Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin

Resveratrol, a bioactive phytoalexin, has been extensively studied as a pharmaceutical and nutraceutical candidate for the treatment of various diseases. Although its therapeutic effects have been largely attributed to its anti-oxidant properties, its underlying mechanisms and dose dependency are no...

Full description

Saved in:
Bibliographic Details
Main Authors: Salooni Khanvilkar, Indraneel Mittra
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/18/1/132
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587707898920960
author Salooni Khanvilkar
Indraneel Mittra
author_facet Salooni Khanvilkar
Indraneel Mittra
author_sort Salooni Khanvilkar
collection DOAJ
description Resveratrol, a bioactive phytoalexin, has been extensively studied as a pharmaceutical and nutraceutical candidate for the treatment of various diseases. Although its therapeutic effects have been largely attributed to its anti-oxidant properties, its underlying mechanisms and dose dependency are not well understood. Recent studies have shown that cell-free chromatin particles (cfChPs), which are released daily from billions of dying cells, can enter circulation and be internalized by healthy cells, wherein they trigger various damaging effects, including double-strand DNA breaks. Notably, deactivating cfChPs using a mixture of resveratrol and copper can neutralize their harmful effects. The addition of copper imparts a novel therapeutic property to resveratrol viz. the generation of reactive oxygen species (ROS), which are capable of deactivating cfChPs without damaging the genomic DNA. This perspective article discusses how the deactivation of cfChPs via the ROS generated by combining resveratrol with copper can have multiple therapeutic effects. Exploiting the damaging effects of ROS to deactivate cfChPs and ameliorate disease conditions may be a viable therapeutic approach.
format Article
id doaj-art-4d675d9d075540afb24909fbceca1217
institution Kabale University
issn 1424-8247
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj-art-4d675d9d075540afb24909fbceca12172025-01-24T13:45:31ZengMDPI AGPharmaceuticals1424-82472025-01-0118113210.3390/ph18010132Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free ChromatinSalooni Khanvilkar0Indraneel Mittra1Translational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai 410210, IndiaTranslational Research Laboratory, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai 410210, IndiaResveratrol, a bioactive phytoalexin, has been extensively studied as a pharmaceutical and nutraceutical candidate for the treatment of various diseases. Although its therapeutic effects have been largely attributed to its anti-oxidant properties, its underlying mechanisms and dose dependency are not well understood. Recent studies have shown that cell-free chromatin particles (cfChPs), which are released daily from billions of dying cells, can enter circulation and be internalized by healthy cells, wherein they trigger various damaging effects, including double-strand DNA breaks. Notably, deactivating cfChPs using a mixture of resveratrol and copper can neutralize their harmful effects. The addition of copper imparts a novel therapeutic property to resveratrol viz. the generation of reactive oxygen species (ROS), which are capable of deactivating cfChPs without damaging the genomic DNA. This perspective article discusses how the deactivation of cfChPs via the ROS generated by combining resveratrol with copper can have multiple therapeutic effects. Exploiting the damaging effects of ROS to deactivate cfChPs and ameliorate disease conditions may be a viable therapeutic approach.https://www.mdpi.com/1424-8247/18/1/132resveratrolcoppercell-free chromatin particlesreactive oxygen speciestherapeuticsnutraceuticals
spellingShingle Salooni Khanvilkar
Indraneel Mittra
Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin
Pharmaceuticals
resveratrol
copper
cell-free chromatin particles
reactive oxygen species
therapeutics
nutraceuticals
title Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin
title_full Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin
title_fullStr Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin
title_full_unstemmed Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin
title_short Copper Imparts a New Therapeutic Property to Resveratrol by Generating ROS to Deactivate Cell-Free Chromatin
title_sort copper imparts a new therapeutic property to resveratrol by generating ros to deactivate cell free chromatin
topic resveratrol
copper
cell-free chromatin particles
reactive oxygen species
therapeutics
nutraceuticals
url https://www.mdpi.com/1424-8247/18/1/132
work_keys_str_mv AT saloonikhanvilkar copperimpartsanewtherapeuticpropertytoresveratrolbygeneratingrostodeactivatecellfreechromatin
AT indraneelmittra copperimpartsanewtherapeuticpropertytoresveratrolbygeneratingrostodeactivatecellfreechromatin